Highlights GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 10:49:26 13/02/2026 GMT			5-day change	1st Jan Change
2,161.50 ^GBX	+0.96%		-1.89%	+18.19%

10:07am	GSK : Receives a Buy rating from Jefferies	ZD
09:52am	Bernstein, Barclays and Deutsche lower Relx	AN

Highlights

07:59am	NatWest results ahead of forecasts, ups dividend 51%	AN
02-11	Bernstein Upbeat on GSK Amid Upcoming Catalysts; Price Target, Forecasts Revised	MT
02-10	European Stocks Mostly Lower in Tuesday Trading; UK Regulator Seeks Views on Apple, Google Competition Commitments	MT
02-10	Quest Diagnostics Incorporated announces an Increase in Equity Buyback	CI
02-10	Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.	CI
02-10	Chinese Regulator Accepts GSK's Arexvy Vaccine for Review	MT
02-10	GSK plc's RSV Vaccine Accepts for Review by China's Center for Drug Evaluation for the Prevention of Lower Respiratory Syncytial Virus Disease	CI
02-06	GSK plc Announces Nucala (Mepolizumab) Approval by European Commission for Treatment of Chronic Obstructive Pulmonary Disease	CI
02-06	Markets Ask the Obvious Question
02-06	GSK Says European Commission Approves Nucala to Treat Chronic Obstructive Pulmonary Disease	MT
02-06	FTSE 100 falls as AI fears pressure data stocks	AN
02-06	UK house prices rise more than expected in January	AN
02-06	GSK Wins EU Nod for Nucala in Uncontrolled Chronic Obstructive PulmonaryDisease	MT
02-06	Markets are seasick
02-06	AlphaValue/Baader Europe Keeps 'Favorable Stance' on GSK After Q4 2025 Beat	MT
02-05	GSK plc: Eventually getting into its stride
02-05	UK Stocks-Factors to watch on February 5	RE
02-04	Novo Nordisk risks weight-loss price war as discount pressures deepen	RE
02-04	UK Shares Hit New Peak Ahead of Central Bank Move; Beazley Surges on Potential Merger	MT
02-04	Novo Nordisk risks weight-loss price war as discount pressures deepen	RE
02-04	Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday Ahead of Alphabet Earnings	MT
02-04	GSK says will run business with discipline, rapidly move resources to support that	RE
02-04	GSK CEO Miels says drugmaker 'heavily' committed to the UK	RE
02-04	GSK CEO Miels says GLP-1 space going to be 'very crowded', vaccines remains core pillar for drugmaker	RE
02-04	FTSE 100 makes record close, GSK at 26-year high after earnings impress	RE